Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adam Hansen

Thoracic Surgery (Cardiothoracic Vascular Surgery) Bridgeport, WV Medical Doctor

NPI 1134193840 CMS profile 96407

527 Medical Park Dr Ste 205, Ste 205, Bridgeport, WV 26330

Open in the dashboard

General payments

$1,536

47 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Adam Hansen of Bridgeport, WV is reported in the CMS Open Payments database as having received $1,536 across 47 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 30th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $29 1
2024 General $120 2
2023 General $393 5
2022 General $161 3
2021 General $307 3
2020 General $346 4
2019 General $180 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adam Hansen
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Adam Hansen were reported at $29. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Adam Hansen Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $180 $886 $178–$3,167 $163
2020 $346 $341 $108–$1,605 $114
2021 $307 $453 $125–$1,886 $132
2022 $161 $695 $180–$2,566 $149
2023 $393 $745 $205–$2,662 $160
2024 $120 $799 $214–$2,967 $164
2025 $29 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Acumed LLC $505 6 payments
  2. Mid-Atlantic Surgical Systems, LLC $330 3 payments
  3. Ethicon US, LLC $141 28 payments
  4. Medical Device Business Services, Inc. $122 1 payment
  5. DePuy Synthes Sales Inc. $112 1 payment
  6. Zimmer Biomet Holdings, Inc. $96 1 payment
  7. Intuitive Surgical, Inc. $79 1 payment
  8. Stryker Corporation $42 1 payment
  9. On Target Laboratories, Inc $29 1 payment
  10. Pinnacle Biologics, Inc $27 1 payment
  11. Other $55 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,157 45 payments
  2. Travel and Lodging $279 1 payment
  3. Consulting Fee $100 1 payment
Products named General payments · program years 2019–2025
  1. MATRIXRIB $234 2 payments
  2. OsteoMed $167 2 payments
  3. LINX Reflux Management System $141 28 payments
  4. AccuShape $139 1 payment
  5. XCM Biologic Tissue Matrix $122 1 payment
  6. NA $112 1 payment
  7. RibLoc Chest $100 1 payment
  8. AdvantageRib $96 1 payment
  9. Da Vinci Surgical System $79 1 payment
  10. RibLoc Chest $79 2 payments
  11. Other $294 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

114

Median for Thoracic Surgery: 42

Drug cost

$540

Median for Thoracic Surgery: $318

Branded share of claims

83.3%

Median for Thoracic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 59 $249
Ondansetron Odt Ondansetron Brand 17 $149
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 19 $92
Tizanidine Hcl Generic 19 $51

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 910 Part D prescribers listed as Thoracic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$66,146

Medicare's payments for the services billed

Medicare patients

137

Average age 72

Services billed

261

81 women, 56 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 66%
Ischemic heart disease 45%
COPD 44%
Cancer 42%
Diabetes 36%
Chronic kidney disease 30%
Depression 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

47 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record